• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Sunscreen regulations take effect

Article

Washington - The Food and Drug Administration’s final rule for sunscreen labeling requirements went into effect Dec. 17, impacting manufacturers with annual product sales of more than $25,000.

Sunscreen regulations take effect

Jan 4, 2013
By: Sarah Thuerk
Dermatology Times E-News

 

Washington - The Food and Drug Administration’s final rule for sunscreen labeling requirements went into effect Dec. 17, impacting manufacturers with annual product sales of more than $25,000.

The FDA’s final rule calls for some manufacturers of over-the-counter sunscreens to pass new broad-spectrum tests. Broad-spectrum sunscreens with sun protection factor (SPF) values of 15 or higher can make claims related to skin cancer protection and early skin aging. Those products that are not broad-spectrum must include a warning that the product will only protect against sunburn, not skin cancer or photoaging.

Manufacturers producing sunscreen products with annual sales of less than $25,000 have until Dec. 17, 2013 to comply to the final rule, according to the FDA. After that date, any sunscreen manufacturers whose products have annual sales of more than $25,000 cannot introduce products to the marketplace that are not compliant with the new rule.

http://dermatologytimes.modernmedicine.com/dermatologytimes/article/articleDetail.jsp?id=801205&sk=7d8edd19cddb63c52eadbbada67b7a35

Related Videos
© 2024 MJH Life Sciences

All rights reserved.